We are bringing in the dawning of the Age of Aquarius https://t.co/dUAo9kUSdw

More from ๐ŸŒนโšœ๏ธ โš”๏ธ๐’ฎ๐’ฝ๐‘’๐“€๐’ฝ๐’พ๐“ƒ๐’ถ๐’ฝ โš”๏ธ โšœ๏ธ ๐ŸŒน

This is definitely a cry for help ... see Gematria below... https://t.co/MoMT21EYD5


https://t.co/A4OTVf76W1


This is what the nurses and doctors are really expressing ๐Ÿ‘‡


They are the โ€œsacrificial offeringsโ€


We are reminded to contribute to have faith

More from For later read

the whole point of Dunks was you could go cop them at VIM whenever you wanted for $65. this shit is like having to enter a raffle to buy milk.


like seriously why not make a ton more of them if they're gonna be so sought-after? they land at outlets? so? nike still makes money off that.

the only reason to keep making them so limited is that they KNOW all that matters is the profit on the flip and if they were readily available FEWER people would want them, not more

the whole system is super broken, but it's just gonna go the way it goes, because at this point it all caters to the secondary market. the only reason Nike can sell Jordan 1s for $200 is because the people buying them can flip them for $500

adjusted for inflation, a $65 AJ1 in 1985 is like $160โ€”and modern-day AJ1s are made from cheaper materials in factories staffed by cheaper workers. they don't HAVE to be $200 retail. but the secondary market nuked the whole concept of what sneakers are "worth"
#IDTwitter #IDFellows
Introducing our new series: โ€œIDFN top 10 articles every fellow should readโ€๐Ÿ”–

#1: SAB management
by @mmcclean1 @LeMiguelChavez
Reviewers @KaBourgi, @IgeGeorgeMD, @Courtcita, @MDdreamchaser

We know is subjective & expect feedback/future improvements ๐Ÿ‘‡

1. Clinical management of Staphylococcus aureus bacteremia: a review.
https://t.co/9tBCtp9mlP
๐Ÿ‘‰ A must read written by Holland et al. where they review the evidence of the management of SAB.

2. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.
https://t.co/XujO68pCuH
๐Ÿ‘‰ID consult associated with reduced inpatient mortality.

3. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia
https://t.co/otcA1pxjAw
๐Ÿ‘‰Predictive risk factors for infective endocarditis, and thus the need for TEE.

4. The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia.
https://t.co/CQZiryVWZz
๐Ÿ‘‰Presence of cefazolin inoculum effect in the infecting isolate was associated with an increase 30-day mortality.

You May Also Like

"I really want to break into Product Management"

make products.

"If only someone would tell me how I can get a startup to notice me."

Make Products.

"I guess it's impossible and I'll never break into the industry."

MAKE PRODUCTS.

Courtesy of @edbrisson's wonderful thread on breaking into comics โ€“
https://t.co/TgNblNSCBj โ€“ here is why the same applies to Product Management, too.


There is no better way of learning the craft of product, or proving your potential to employers, than just doing it.

You do not need anybody's permission. We don't have diplomas, nor doctorates. We can barely agree on a single standard of what a Product Manager is supposed to do.

But โ€“ there is at least one blindingly obvious industry consensus โ€“ a Product Manager makes Products.

And they don't need to be kept at the exact right temperature, given endless resource, or carefully protected in order to do this.

They find their own way.